NCT04514523View on ClinicalTrials.gov

QBSAfe: A Novel Approach to Diabetes Management Focused on Quality of Life, Burden of Treatment, Social Integration and Avoidance of Future Events

NACompletedINTERVENTIONAL
Enrollment

91

Participants

Timeline

Start Date

April 28, 2020

Primary Completion Date

September 22, 2020

Study Completion Date

September 22, 2020

Conditions
DiabetesDiabetes Mellitus
Interventions
OTHER

QBSAfe Toolkit

The QBSAfe toolkit focuses on palliating symptoms, alleviating burden of treatment, facilitating social connections, and optimizing treatment safety.

Trial Locations (3)

55905

Mayo Clinic, Rochester

06520

Yale University, New Haven

06706

Trinity Health of New England, Waterbury

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

Trinity Health Of New England

OTHER

collaborator

National Institute on Aging (NIA)

NIH

lead

Yale University

OTHER

NCT04514523 - QBSAfe: A Novel Approach to Diabetes Management Focused on Quality of Life, Burden of Treatment, Social Integration and Avoidance of Future Events | Biotech Hunter | Biotech Hunter